<bill session="116" type="h" number="4712" updated="2019-10-24T19:15:29Z">
  <state datetime="2019-10-17">REFERRED</state>
  <status>
    <introduced datetime="2019-10-17"/>
  </status>
  <introduced datetime="2019-10-17"/>
  <titles>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.</title>
    <title type="short" as="introduced">Fairness in Orphan Drug Exclusivity Act</title>
    <title type="short" as="introduced">Fairness in Orphan Drug Exclusivity Act</title>
    <title type="display">Fairness in Orphan Drug Exclusivity Act</title>
  </titles>
  <sponsor bioguide_id="D000631"/>
  <cosponsors>
    <cosponsor bioguide_id="C001103" joined="2019-10-17"/>
    <cosponsor bioguide_id="M001180" joined="2019-10-17"/>
    <cosponsor bioguide_id="V000131" joined="2019-10-17"/>
  </cosponsors>
  <actions>
    <action datetime="2019-10-17">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-10-17" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
